HYTALIF Trademark

Trademark Overview


On Monday, January 18, 2016, a trademark application was filed for HYTALIF with the United States Patent and Trademark Office. The USPTO has given the HYTALIF trademark a serial number of 79184536. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Sunday, April 10, 2022. This trademark is owned by Novartis AG. The HYTALIF trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preven...
hytalif

General Information


Serial Number79184536
Word MarkHYTALIF
Filing DateMonday, January 18, 2016
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateSunday, April 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, April 10, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Wednesday, November 16, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tuesday, November 15, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, July 27, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 5, 2018FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 5, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, November 17, 2017NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, August 16, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 16, 2017NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, July 5, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, July 5, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 28, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 28, 2016FINAL REFUSAL E-MAILED
Monday, November 28, 2016FINAL REFUSAL WRITTEN
Friday, November 4, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 3, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 3, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 26, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 26, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 2, 2016REFUSAL PROCESSED BY IB
Thursday, May 5, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 5, 2016REFUSAL PROCESSED BY MPU
Thursday, May 5, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 4, 2016NON-FINAL ACTION WRITTEN
Monday, May 2, 2016ASSIGNED TO EXAMINER
Friday, March 18, 2016APPLICATION FILING RECEIPT MAILED
Monday, March 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 11, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 10, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB